Data as of Apr 17
| +0.23 / +2.52%|
The 2 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 12.00, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +28.34% increase from the last price of 9.35.
The current consensus among 3 polled investment analysts is to Buy stock in Accretive Health Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.